Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity.
Mathus-Vliegen, E M H
Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity. [electronic resource] - Alimentary pharmacology & therapeutics Mar 2004 - 601-11 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0269-2813
10.1046/j.1365-2036.2004.01812.x doi
Adult
Anti-Obesity Agents--therapeutic use
Body Weight
Cholecystokinin--metabolism
Female
Gallbladder--metabolism
Humans
Lactones--therapeutic use
Lipase--antagonists & inhibitors
Male
Middle Aged
Obesity--drug therapy
Orlistat
Weight Loss
Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity. [electronic resource] - Alimentary pharmacology & therapeutics Mar 2004 - 601-11 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0269-2813
10.1046/j.1365-2036.2004.01812.x doi
Adult
Anti-Obesity Agents--therapeutic use
Body Weight
Cholecystokinin--metabolism
Female
Gallbladder--metabolism
Humans
Lactones--therapeutic use
Lipase--antagonists & inhibitors
Male
Middle Aged
Obesity--drug therapy
Orlistat
Weight Loss